David Huang, MD


Treating Trigeminal Neuralgia With Stereotactic Radiosurgery via CyberKnife: David Huang, MD

The radiation oncologist at Cooperman Barnabas Medical Center talked about how trigeminal neuralgia can be effectively treated with stereotactic radiosurgery using the CyberKnife offering pain relief without the need for invasive surgery. [WATCH TIME: 6 minutes]

Daniel Ackerman, MD, FAAN


Addressing US Preventive Services Task Force Aspirin Recommendations for Stroke

In a time when complex medical communication to the public is on display, the need to ensure patient comprehension is of utmost importance for vascular neurologists.

Afolasade Fakolade, PhD


Lessons from a Multiple Sclerosis Feasibility Study Focused on Movement Medicine: Afolasade Fakolade, PhD

The assistant professor at Queen’s University discussed results from a pilot trial that evaluated the impact of a dyadic physical activity intervention among both caregivers and patients with multiple sclerosis. [WATCH TIME: 3 minutes]

Erica A. Schuyler, MD


AUPN Leadership Minute Episode 37: International Physicians in Neurology

Episode 37 of the AUPN Leadership Minute features David G. Standaert, MD, PhD, of the University of Alabama at Birmingham; and Erica A. Schuyler, MD, of the University of Connecticut. [WATCH TIME: 5 minutes]

Patricia Bobryk, MHS, MSCS, PT, ATP


Physical Therapy Approach for Fatigue Management in Multiple Sclerosis

Fatigue, although not immediately visible, is among the most debilitating symptoms of multiple sclerosis, affecting not only patients' day-to-day functioning but their quality of life.

Stephan Züchner, MD, PhD


The Potential of Genetic Therapies in Neuromuscular Diseases: Stephan Züchner, MD, PhD

At the 2023 MDA conference, the professor for human genetics and neurology at the University of Miami Miller School of Medicine talked about the role of genetics in neuromuscular diseases and potential therapies. [WATCH TIME: 5 minutes]

Elanda Williams, MA


Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMA

Advocacy organization Cure SMA provides insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in SMA.

Paul Melmeyer, MPP


Advocacy and Progress in Rare Neuromuscular Diseases From a Policy Standpoint: Paul Melmeyer, MPP

In honor of Rare Disease Day, the vice president of public policy and advocacy at the Muscular Dystrophy Association shared his perspective of advocacy and policy progress in the realm of rare neuromuscular diseases. [WATCH TIME: 6 minutes]

Sanjeev Kothare, MD


Sudden Unexpected Death in Epilepsy Linked With Sleep: Sanjeev Kothare, MD

The division director of pediatric neurology, and director of the pediatric sleep program at Cohen, Children's Medical Center, Northwell Health, spoke about sudden unexpected death in epilepsy and sleep at the 2022 AES Conference. [WATCH TIME: 3 minutes]

Justin Klee


Reactions to FDA Advisory Panel Decision on AMX0035: Justin Klee; Josh Cohen, BSc

The co-CEOs and co-founders of Amylyx Pharmaceuticals discussed their immediate thoughts to the recent FDA AdComm meeting, which voted against evidence of efficacy for AMX0035 in ALS. [WATCH TIME: 3 minutes]

Yasar Torres-Yaghi, MD


Reasons to Attend the 2023 Advanced Therapeutics in Movement & Related Disorders Congress: Fernando Pagan, MD; Yasar Torres-Yaghi, MD

The course directors of the 2023 ATRMD Congress provided an overview of the upcoming meeting, and the educational benefits clinicians can gain from attending. [WATCH TIME: 6 minutes]

Feixiong Cheng, PhD


Understanding the Microglial Immunologic Sex Differences in Alzheimer Disease: Feixiong Cheng, PhD

The assistant professor at Cleveland Clinic discussed findings from a recently published study that provided insights on the understanding of the molecular basis for female predominance in Alzheimer disease. [WATCH TIME: 3 minutes]

Joseph R. Berger, MD


AUPN Leading Edge Episode 4: How Much Is a Neurologist Worth? Factoring the Downstream

AUPN Leading Edge Episode 4 features Rohit Das, MD, and Joseph R. Berger, MD, who discuss how neurologists are undervalued in academic and non-academic settings when their compensation is predicated on RVUs alone. [LISTEN TIME: 26 minutes]

Virendra Mishra, PhD


Virendra Mishra, PhD: Previous Data on Parkinson Disease Dementia

The Cleveland Clinic researcher discussed the unknowns about Parkinson disease dementia and what has been previously observed in clinical studies.

Klaus Romero, MD, MS, FCP


Identifying Impactful Biomarkers of Alzheimer Disease: Sudhir Sivakumaran, PhD; Klaus Romero, MD, MS, FCP

The duo from the Critical Path Institute detailed the thought process behind evaluating the importance of specific biomarkers and their relation to disability progression in Alzheimer disease.

Safia Abdillahi, ACNP-BC, DNP


Emerging Therapies in Movement Disorders and Chronic Care Management for Parkinson Disease: Safia Abdillahi, ACNP-BC, DNP

The nurse practitioner in the movement disorder division at Georgetown University Hospital discussed differences in available therapies for movement disorders versus multiple sclerosis and using a chronic care management model in Parkinson disease. [WATCH TIME: 5 minutes]

Hai Sun, MD, PhD


Advancements in Minimally Invasive Epilepsy Surgery Techniques: Hai Sun, MD, PhD

The associate professor of neurosurgery at Robert Wood Johnson Medical School talked about minimally invasive techniques and neurostimulation strategies to make epilepsy surgery safer and more effective. [WATCH TIME: 7 minutes]

Nicholas J. Silvestri, MD, FAAN


Improving Patient Communication in MG

Expert neurologists share thoughts on how to improve patient/physician communication and how listening to the patient needs will aid in managing MG.

Elizabeth K. Seng, PhD


Reframing the Communication of Lifestyle Changes for Migraine Management: Elizabeth Seng, PhD

The associate professor at Yeshiva University and Albert Einstein College of Medicine explored the challenge of discussing lifestyle changes for patients with migraine, noting that lifestyle modifications can be a valuable addition to migraine treatment. [WATCH TIME: 3 minutes]

Afsara Zaheed


Understanding Race-Gender Associations in Insomnia Patterns and Late-Life Memory Trajectories: Afsara Zaheed

The graduate student at the University of Michigan provided insight on her study examining longitudinal patterns of difficulty initiating sleep and their associations with subsequent memory trajectories among different races and genders. [WATCH TIME: 3 minutes]

Shauna Brady BN, MN, CNN(C), NCA, MSCN


Burnout Among Healthcare Providers Affects Worker Quality of Life and Reduces Quality of Patient Care

Many programs and activities at the 2023 CMSC Annual Meeting focused on burnout prevention and supporting the current and future MS care workforce.

Sanjay Iyer, MD


Unmet Needs and Advice for the Management of OFF Episodes in Parkinson Disease

Expert neurologists provide insight on unmet needs, challenges to improve access to care, and highlight clinical pearls for the management of OFF episodes in Parkinson disease.

Martin Sadowski, MD, PhD


Differences Between Antiamyloid Therapies Lecanemab and Donanemab: Martin Sadowski, MD, PhD

The professor of neurology, psychiatry, and pharmacology at the NYU Grossman School of Medicine commented on the differences in mechanisms and clinical trial data between lecanemab and donanemab. [WATCH TIME: 5 minutes]

Natalie L. Goedeker, CPNP


Clinical Trial Experiences Managing Adverse Events in Gene Therapy for DMD: Natalie L. Goedeker, CPNP

At the 2023 MDA Conference, a neurology nurse practitioner in the Neuromuscular Division at Washington University in St. Louis talked about adverse event management of gene therapies in Duchenne muscular dystrophy. [WATCH TIME: 2 minutes]

Anne Kever, PhD


Expanding Research on MS Diagnosis Disclosure and Long-Term Impacts: Anne Kever, PhD

The postdoctoral researcher at Columbia University discussed the long-term plans to gain a better understanding of MS diagnosis disclosure and how it can impact other qualities of life.

Elissa Yozawitz, MD


The Classification, Management, and Future Directions of Neonatal Seizures: Elissa Yozawitz, MD

The associate professor of neurology at Albert Einstein College of Medicine talked about a review on neonatal seizures recently published in the New England Journal of Medicine. [WATCH TIME: 5 minutes]

Prabhat Gottipati


Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Kristen Krysko, MD


Advice for Managing MS

Joseph R. Berger, MD, and Fred D. Lublin, MD, offer advice to community physicians and neurologists in managing patients with multiple sclerosis.

Carl B. Heilman, MD


A New Approach to Communicating Hydrocephalus: An Overdue Opportunity

A pair of cerebrovascular and neurosurgery experts discuss a novel approach to communicating hydrocephalus with an arachnoid granulation using a miniature implant, delivered via a percutaneous endovascular catheter.

Julie Pilitsis, MD, PhD, MBA


Evolving Role of Deep Brain Stimulation for Parkinson Disease, Essential Tremor: Julie Pilitsis, MD, PhD, MBA

The neurosurgeon at Marcus Neuroscience Institute, Baptist Health, provided perspective on the advances of DBS and other invasive procedures for patients with degenerative disorders. [WATCH TIME: 4 minutes]

© 2024 MJH Life Sciences

All rights reserved.